milvexian
bms,Janssen
['factor xi', 'milvexian']
the new factor xi inhibitor antithrombotic, milvexian, has shown promising results in a dose-finding phase 2 trial in patients with acute ischemic stroke or tia, when given in addition to dual antiplatelet therapy. #esccongress #neurotwitter 
Medscape Neurology provides you with breaking medical news; reference on drugs,diseases,and procedures; and free CME.